Trial Profile
Use of Rosuvastatin to Achieve Lipid Targets in African American Subjects With Cerebrovascular Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2013
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cerebrovascular disorders; Hypercholesterolaemia; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- 18 Nov 2013 New trial record